Log in

Relevant bibliographies by topics / Cancer patients / Journal articles

Journal articles on the topic 'Cancer patients'

To see the other types of publications on this topic, follow the link: Cancer patients.

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cancer patients.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shams, Salima. "ENSEIGNEMENT AUX PATIENTS : Counselling pour les patients atteints d’un cancer de la bouche." Canadian Oncology Nursing Journal 34, no. 2 (April 30, 2024): 238–44. http://dx.doi.org/10.5737/23688076342238.

Full text

Abstract:

L’objectif du présent article est de résumer les aspects centraux des soins aux patients atteints d’un cancer avancé de la bouche avec métastases dans la région de la tête et du cou. Ces patients sont traités par approche multimodale. L’intervention chirurgicale limite leur capacité de parler et d’avaler, tandis que la chimiothérapie et la radiothérapie peuvent entraîner nausées et vomissements, diarrhée, mucite, cystite, déshydratation, néphrotoxicité, dermatite, dépression médullaire et carences alimentaires entraînant une perte de poids. Il est possible de contrer ces effets toxiques à l’aide de mesures d’autosoins. Dans le cadre de leurs interventions d’enseignement, les infirmières en oncologie pourraient transmettre aux patients et aux familles les connaissances nécessaires à l’application de ces mesures d’autosoins. Mots-clés : cancer avancé de la bouche, cancer de la tête et du cou, counselling, mesures d’autosoins

APA, Harvard, Vancouver, ISO, and other styles

2

Sartip Tahir, Bahez, and Bahar Nasradeen Majeed. "QUALITY OF LIFE OF PEDIATRIC CANCER PATIENTS UNDERGOING CANCER THERAPY IN SULAIMANI CITY, IRAQ (PATIENT’S REPORT)." Journal of Sulaimani Medical College 11, no. 3 (September 21, 2021): 359–70. http://dx.doi.org/10.17656/jsmc.10321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rajvi, Patel, Park Jennifer, Shah Ankit, and Wasif Saif Muhammad. "COVID-19 and Cancer Patients." Cancer Medicine Journal 3, no. 1 (June 30, 2020): 40–48. http://dx.doi.org/10.46619/cmj.2020.3-1019.

Full text

Abstract:

COVID-19 has now been declared a global pandemic with evolving incidence rates and fatalities. It is important to identify vulnerable populations who will be impacted most by this pandemic leading to higher mortality rates compared to the general healthy population. Although older patients and patients with co-morbidities fall into this vulnerable group, patients with hematologic and oncologic malignancies on active cytotoxic treatments are at even greater risk as they are both myelosuppressed and immunosuppressed. In addition to following the universal guidelines recommended by the Centers for Disease Control (CDC), it is important to also institute guidelines for cancer centers to help protect this vulnerable population. We review the current data, risks, and recommendations for COVID-19 in cancer patients.

APA, Harvard, Vancouver, ISO, and other styles

4

Sato, Akira, Eiji Aramaki, Yumiko Shimamoto, Shiro Tanaka, and Koji Kawakami. "Blog Posting After Lung Cancer Notification: Content Analysis of Blogs Written by Patients or Their Families." JMIR Cancer 1, no. 1 (May 18, 2015): e5. http://dx.doi.org/10.2196/cancer.3883.

Full text

Abstract:

Background The advent and spread of the Internet has changed the way societies communicate. A portion of information on the Internet may constitute an important source of information concerning the experiences and thoughts of patients and their families. Patients and their families use blogs to obtain updated information, search for alternative treatments, facilitate communication with other patients, and receive emotional support. However, much of this information has yet to be actively utilized by health care professionals. Objective We analyzed health-related information in blogs from Japan, focusing on the feelings and satisfaction levels of lung cancer patients or their family members after being notified of their disease. Methods We collected 100 blogs written in Japanese by patients (or their families) who had been diagnosed with lung cancer by a physician. These 100 blogs posts were searchable between June 1 and June 30, 2013. We focused on blog posts that addressed the lung cancer notification event. We analyzed the data using two different approaches (Analysis A and Analysis B). Analysis A was blog content analysis in which we analyzed the content addressing the disease notification event in each blog. Analysis B was patient's dissatisfaction and anxiety analysis. Detailed blog content regarding patient's dissatisfaction and anxiety at the individual sentence level was coded and analyzed. Results The 100 blog posts were written by 48 men, 46 women, and 6 persons whose sex was undisclosed. The average age of the blog authors was 52.4 years. With regard to cancer staging, there were 5 patients at Stage I, 3 patients at Stage II, 14 patients at Stage III, 21 patients at Stage IV, and 57 patients without a disclosed cancer stage. The results of Analysis A showed that the proportion of patients who were dissatisfied with the level of health care exceeded that of satisfied patients (22% vs 8%). From the 2499 sentences in the 100 blog posts analyzed, we identified expressions of dissatisfaction and anxiety in 495 sentences. Our results showed that there were substantially more posts concerning “Way of living, reasons for living, set of values” and “Relationships with medical staff (own hospital)” than in previous studies (Analysis B). Conclusions This study provides insight into the feelings of dissatisfaction and anxieties held by lung cancer patients and their families, including those regarding the “Way of living, reasons for living, set of values” and “Relationship with medical staff (own hospital),” which were inaccessible in previous survey analyses. When comparing information obtained from patients’ voluntary records and those from previous surveys conducted by health care institutions, it is likely that the former would be more indicative of patients’ actual opinions and feelings. Therefore, it is important to utilize such records as an information resource.

APA, Harvard, Vancouver, ISO, and other styles

5

KG, Nayana, Panayappan L, Krishna Kumar K, and Jayaprakash K. "Thromboprophylaxis in Cancer Patients-A Review." Scholars Journal of Applied Medical Sciences 4, no. 6 (June 2016): 1953–55. http://dx.doi.org/10.21276/sjams.2016.4.6.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Tomilová, Marina, and Kristýna Frühaufová. "Female fertility preservation in cancer patients." Česká gynekologie 87, no. 5 (October 24, 2022): 356–61. http://dx.doi.org/10.48095/cccg2022356.

Full text

Abstract:

Fertility preservation in cancer patients or oncofertility is a relatively new trend in modern medicine. In patients with unfulfilled reproductive plans, the possibility of starting a family is one of the key parameters of quality of life after overcoming a cancer. Guidelines have existed since 2013 and in 2020 the European Society of Human Reproduction and Embryology has also published a guideline, but the main problem of their application in clinical practice is the lack of information for both patients and, unfortunately, professionals, as well as the high cost of treatment. From 2022, health insurance companies in the Czech Republic partially cover the expenses for fertility preservation treatment for cancer patients. The possibilities of oncofertility are based, on the one hand, on improving the results of oncological treatment, on the other hand, on the development of reproductive technologies. Thanks to progress in treatment, up to 80% of pediatric oncology patients survive into adulthood, but chemotherapy, especially highly eff ective alkylating agents, is associated with a high risk of impaired fertility. This article overviewed modern global trends of fertility preservation in women undergoing cancer treatment based on an analysis of the English-language literature over the past 5 years. Key words: oncofertility – fertility preservation – oocyte cryopreservation – embryo cryopreservation – ovarian tissue cryopreservation – oocyte in vitro maturation – gonadotropin-releasing hormone agonists

APA, Harvard, Vancouver, ISO, and other styles

7

Hussain, Dr Hidayath. "Pulmonary Tuberculosis in Breast Cancer Patients." Journal of Medical Science and clinical Research 12, no. 01 (January 31, 2024): 57–60. http://dx.doi.org/10.18535/jmscr/v12i01.09.

Full text

Abstract:

Background ● The Population with malignancy is growing worldwide. ● TB remains most common infectious disease worldwide that leads to high mortality. ● The relationship between TB and cancer is of dual nature. Patients with malignant diseases are at increased risk for diseases caused by mycobacteria. Patients with depressed cellular immunity such as those who have cancer, transplant patients and patients on immunosuppressive therapy are at particular risk. ● The risk of TB in patients with malignancy is due to immunosuppression from the cancer itself or from the chemotherapy. ● The incidence of pulmonary TB has been therefore reportedly increasing in patients with cancer in both pulmonary and non pulmonary cancers. ● The incidence of TB in cancer patients is also increasing annually from 3% to 23 % in 2022. ● Patients with diabetes, HIV, and cancer patients and persons on corticosteroid frequently present with lower zone tuberculosis. ● It affects females more commonly as compared to males and tuberculosis should be looked in females with lower lung field lesions. ● Cough is the most frequent presentation of lower zone TB as compared to upper zone TB. ● In immunocompromised patients, isolated lower lung field were involved in almost 23.3% patients.

APA, Harvard, Vancouver, ISO, and other styles

8

Ishaq, Aliya. "Age Related Disparities in Colorectal Cancer Patients." Journal of Clinical and Laboratory Research 3, no. 3 (September 11, 2021): 01–04. http://dx.doi.org/10.31579/2768-0487/064.

Full text

Abstract:

Background: There is an evident change in the colorectal cancer demographic over the period. This change is more marked in the age distribution and location of the tumor. It has practical implications, in regards to develop cancer awareness programs and screening protocols. Keeping in view that Pakistan is one of the countries with a high number of the young population this study is carried out to make a comparative analysis of this trend in our population. Material and methods: Colorectal cancer patients presented in Sindh Institute of urology and transplantation from January 2011 till December 2020 was reviewed retrospectively. All patients were divided into two groups, Group A young age population and Group B old age population. Subgroup analysis of study period was performed to check the progressive change in the trend of stage and clinical characteristics of colorectal cancer patients. Data reviewed from the patient’s files and collected as per Proforma requirement. Result: Total of 612 patients with colorectal cancer presented between 2011 till 2020.Among these patients 243 (39.7%) presented between January 2011 till December 2015. Patients age 50 years and younger were 410 (66.8%). Results showed a statistically significant association between and patient’s age and location of tumor such that left-sided colonic cancer and rectal cancer were more common in the young population. Subgroup analysis according to the study period showed that there is a change in the trend of disease presentation. Right-sided colonic cancer presentation decreased in the younger population over the period while simultaneously left-sided colonic cancer and rectal cancer presentation increased. Conclusion: The incidence of left-sided colonic and rectal cancer has been increased in the younger population over the specified period while there was no association between right-sided colon cancer and age noticed.

APA, Harvard, Vancouver, ISO, and other styles

9

Pirbudak, Lütfiye. "Characteristics of pain in lung cancer patients." Turkish Journal of Thoracic and Cardiovascular Surgery 21, no. 4 (October 7, 2013): 995–99. http://dx.doi.org/10.5606/tgkdc.dergisi.2013.7211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

An, Lawrence C., Lauren Wallner, and Matthias Alexander Kirch. "Online Social Engagement by Cancer Patients: A Clinic-Based Patient Survey." JMIR Cancer 2, no. 2 (August 19, 2016): e10. http://dx.doi.org/10.2196/cancer.5785.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Groen, Wim G., Wilma Kuijpers, Hester SA Oldenburg, Michel WJM Wouters, Neil K. Aaronson, and Wim H. van Harten. "Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study." JMIR Cancer 3, no. 2 (August 8, 2017): e10. http://dx.doi.org/10.2196/cancer.7443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Mensah-Osman, Edith J. "Insomnia in cancer patients." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e18657-e18657. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e18657.

Full text

Abstract:

e18657 Background: As new treatments extend patient survival, the quality of their lives (QoL) grows in importance. QoL may differentiate alternative treatments, and QoL assessment has become a standard component of treatment evaluations. Sleep is a key component of QoL. Insomnia can worsen pain, fatigue, depression and cognitive impairments in cancer patients. Inappropriate treatments for insomnia can further worsen these and interact with chemotherapy medications. Recognizing this, in 2019 the American Society of Clinical Oncology identified Insomnia as a key patient-reported outcome performance measure (PRO-PM) for the National Quality Forum to consider. Methods: Through review of the scientific literature the project identified specific cancers and their treatments where treating Insomnia can have a significant impact on patient QoL. PubMed, Pharmapendium, and Science Direct databases were used. Search terms included “insomnia demographics, epidemiology of insomnia in cancer, insomnia in tumor types, cancer insomnia, insomnia associated hormonal treatment, insomnia in patients awaiting cancer diagnosis; insomnia in cancer care-givers, insomnia in cancer survivors, cancers treated with corticosteriods”. Original research articles in English that used human subjects between January 1, 1993 and January 31, 2020 were included. Results: Insomnia is associated with specific tumor types: brain tumors, breast cancer, gastrointestinal cancer, leukemia, lymphoma, multiple myelomaand terminal cancer. Autoimmune causes of insomnia in paraneoplastic syndromes. Insomnia is prevalent in oncology patients being evaluated, awaiting diagnosis and treatment. Age and gender are demographic factors associated with oncology insomnia. Insomnia is associated with specific antineoplastic agents. Corticosteroid use is associated with insomnia, before, during and after cancer treatment. Insomnia in cancer survivors starts during their treatment and may persist for years. Conclusions: Specific demographics, cancers and treatments are associated with insomnia. Insomnia often occurs in patients undergoing evaluations for cancer. Insomnia is often not recognized and not treated in oncology patients. Insomnia that is not addressed during cancer treatment often persists in cancer survivors. There is the need to investigate whether treating insomnia early in cancer patients during their course of treatment can reduce symptoms such as fatigue and improve their QOL.

APA, Harvard, Vancouver, ISO, and other styles

13

Mensah-Osman, Edith J. "Insomnia in cancer patients." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e18657-e18657. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e18657.

Full text

Abstract:

e18657 Background: As new treatments extend patient survival, the quality of their lives (QoL) grows in importance. QoL may differentiate alternative treatments, and QoL assessment has become a standard component of treatment evaluations. Sleep is a key component of QoL. Insomnia can worsen pain, fatigue, depression and cognitive impairments in cancer patients. Inappropriate treatments for insomnia can further worsen these and interact with chemotherapy medications. Recognizing this, in 2019 the American Society of Clinical Oncology identified Insomnia as a key patient-reported outcome performance measure (PRO-PM) for the National Quality Forum to consider. Methods: Through review of the scientific literature the project identified specific cancers and their treatments where treating Insomnia can have a significant impact on patient QoL. PubMed, Pharmapendium, and Science Direct databases were used. Search terms included “insomnia demographics, epidemiology of insomnia in cancer, insomnia in tumor types, cancer insomnia, insomnia associated hormonal treatment, insomnia in patients awaiting cancer diagnosis; insomnia in cancer care-givers, insomnia in cancer survivors, cancers treated with corticosteriods”. Original research articles in English that used human subjects between January 1, 1993 and January 31, 2020 were included. Results: Insomnia is associated with specific tumor types: brain tumors, breast cancer, gastrointestinal cancer, leukemia, lymphoma, multiple myelomaand terminal cancer. Autoimmune causes of insomnia in paraneoplastic syndromes. Insomnia is prevalent in oncology patients being evaluated, awaiting diagnosis and treatment. Age and gender are demographic factors associated with oncology insomnia. Insomnia is associated with specific antineoplastic agents. Corticosteroid use is associated with insomnia, before, during and after cancer treatment. Insomnia in cancer survivors starts during their treatment and may persist for years. Conclusions: Specific demographics, cancers and treatments are associated with insomnia. Insomnia often occurs in patients undergoing evaluations for cancer. Insomnia is often not recognized and not treated in oncology patients. Insomnia that is not addressed during cancer treatment often persists in cancer survivors. There is the need to investigate whether treating insomnia early in cancer patients during their course of treatment can reduce symptoms such as fatigue and improve their QOL.

APA, Harvard, Vancouver, ISO, and other styles

14

Drewes, Caroline, Thomas Kirkovits, Daniel Schiltz, Timo Schinkoethe, Renate Haidinger, Ursula Goldmann-Posch, Nadia Harbeck, and Rachel Wuerstlein. "EHealth Acceptance and New Media Preferences for Therapy Assistance Among Breast Cancer Patients." JMIR Cancer 2, no. 2 (September 14, 2016): e13. http://dx.doi.org/10.2196/cancer.5711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Beechey-Newman, N., and D. Kulkarni. "Cancer in older patients." Reviews in Clinical Gerontology 13, no. 3 (August 2003): 203–13. http://dx.doi.org/10.1017/s0959259803001035.

Full text

Abstract:

As the number of people living to reach old age increases, so the proportion of cancers presenting in this age group increases to an even greater degree. Although 70% of all cancers in men and women occur over the age of 65 and in the over-75s, who are perhaps more appropriately classified as ‘elderly’, the figures are still very high (46% of all cancers occur in women over 75 and 35% in men over 75). As a consequence, cancer is rapidly becoming a problem of late life, and the management of patients in old age is an important part of general oncology. The magnitude of the overlap between old age and cancer is increasing because of improved life expectancy, more sensitive methods of diagnosing cancer and the biological fact that most cancers occur more commonly with increasing age. It is interesting, however, to put these figures into a more general context by examining the different causes of death in older patients by decade.

APA, Harvard, Vancouver, ISO, and other styles

16

Gupta, Surabhi. "Pattern of Bacterial Infections in Cancer Patients -Experience from a Tertiary Cancer Center." Cancer Research and Cellular Therapeutics 6, no. 4 (June 30, 2022): 01–04. http://dx.doi.org/10.31579/2640-1053/120.

Full text

Abstract:

It is a general belief that cancer patients are more prone to infections, particularly bacterial infections. Firstly, disease itself present an immuno-compromised status, secondarily chemotherapy and radiotherapy further suppress the immunity level which is further overburden by poor nutritional state and poor hygienic conditions in these patients. With the invent of better diagnostic modalities and many technological advancement in treatment delivery, the mortality rates have fallen over the past years, but infection remains a primary or associated cause of death, with bacteria most commonly accounting for infection-associated mortality, followed by fungi. The management of the infections is based on the use of appropriate empirical antimicrobial therapeutic agents with a comprehensive understanding of pathogens which are the commonly encountered in cancer patients in day-to-day practice and also understanding of antibiotic sensitivity patterns. Though the empirical use of antibiotics has reduced the mortality in patients but has also led to the menace of multidrug-resistant bacteria.

APA, Harvard, Vancouver, ISO, and other styles

17

Verberne, Suzan, Anika Batenburg, Remco Sanders, Mies van Eenbergen, Enny Das, and Mattijs S. Lambooij. "Analyzing Empowerment Processes Among Cancer Patients in an Online Community: A Text Mining Approach." JMIR Cancer 5, no. 1 (April 17, 2019): e9887. http://dx.doi.org/10.2196/cancer.9887.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Silva, Dulciléia Martins da, Carla Viana Dendasck, and Euzébio de Oliveira. "The Social Worker’s Attendance to Cancer Patients." Revista Científica Multidisciplinar Núcleo do Conhecimento 05, no. 08 (November 26, 2017): 39–51. http://dx.doi.org/10.32749/nucleodoconhecimento.com.br/health/patient-oncological.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Kumar, Rakesh. "Prevalence of Anxiety and Depression among Cancer Patients." Journal of Medical Science And clinical Research 04, no. 11 (November 6, 2016): 13696–599. http://dx.doi.org/10.18535/jmscr/v4i11.30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Amirifard, Nasrin, Edris Sadeghi, and Mansour Choubsaz. "Triple-Negative Breast Cancer Survival in Kurdish Patients." Scholars Journal of Applied Medical Sciences 4, no. 7 (July 2016): 2732–35. http://dx.doi.org/10.21276/sjams.2016.4.7.89.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sirohi, Sanya, and Dr Pragyan Dangwal. "Body Image, Relationships, And Hope Among Cancer Patients." International Journal of Research Publication and Reviews 4, no. 4 (April 27, 2023): 5162–73. http://dx.doi.org/10.55248/gengpi.234.4.38516.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

N T, Sindumol, and P. T Baburaj. "Quality of Life of Patients with Gynaecological Cancer." International Journal of Science and Research (IJSR) 13, no. 5 (May 5, 2024): 925–27. http://dx.doi.org/10.21275/sr24513223732.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Hartkopf, Andreas D., Joachim Graf, Elisabeth Simoes, Lucia Keilmann, Nina Sickenberger, Paul Gass, Diethelm Wallwiener, et al. "Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients." JMIR Cancer 3, no. 2 (August 7, 2017): e11. http://dx.doi.org/10.2196/cancer.6996.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Köhle, Nadine, Constance HC Drossaert, Suzan Oosterik, Karlein MG Schreurs, Mariët Hagedoorn, Cornelia F. van Uden-Kraan, Irma M. Verdonck-de Leeuw, and Ernst T. Bohlmeijer. "Needs and Preferences of Partners of Cancer Patients Regarding a Web-Based Psychological Intervention: A Qualitative Study." JMIR Cancer 1, no. 2 (December 29, 2015): e13. http://dx.doi.org/10.2196/cancer.4631.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Young-Afat, Danny A., Carla H. van Gils, David J. Bruinvels, Carmen C. van der Pol, Arjen J. Witkamp, Sieta Sijtsema, Yvette Jonasse, et al. "Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation." JMIR Cancer 2, no. 1 (June 7, 2016): e8. http://dx.doi.org/10.2196/cancer.5334.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Smith, Katherine Clegg, Elliott Tolbert, Susan M. Hannum, Archana Radhakrishnan, Kelsey Zorn, Amanda Blackford, Stephen Greco, Karen Smith, and Claire F. Snyder. "Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled Trial." JMIR Cancer 2, no. 2 (August 30, 2016): e12. http://dx.doi.org/10.2196/cancer.5947.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Alpert, Jordan M., Bonny B. Morris, Maria D. Thomson, Khalid Matin, and Richard F. Brown. "Implications of Patient Portal Transparency in Oncology: Qualitative Interview Study on the Experiences of Patients, Oncologists, and Medical Informaticists." JMIR Cancer 4, no. 1 (March 26, 2018): e5. http://dx.doi.org/10.2196/cancer.8993.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sodhi, Jaspreet Kaur, and Riya Sood. "An Exploratory Study to Assess the Relationship between Cancer Awareness and Patient’s Response to the Cancer Diagnosis among Patients in Selected Hospital, Ludhiana, Punjab." International Journal of Practical Nursing 4, no. 3 (2016): 129–31. http://dx.doi.org/10.21088/ijpn.2347.7083.4316.3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Vyas, Tarun, Rangoli Bhargava, and Ashish Sharma. "Comparative Study of Serum Lipid Profile Parameters for Oral Cancer and Non Oral Cancer Patients." International Journal Of Community Health And Medical Research 2, no. 2 (June 20, 2106): 49–55. http://dx.doi.org/10.21276/ijchmr.2016.2.2.08.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Priego, Paola Iturralde Rosas. "Breast Cancer in Young Patients: Same or Different Entity?" Women's Health Science Journal 3, no. 2 (2019): 1–6. http://dx.doi.org/10.23880/whsj-16000133.

Full text

Abstract:

Overview Breast cancer is the most common pathology in women of reproductive age; approximately 7% of breast carcinomas are diagnosed in women less than 40 years of age, corresponding to more than 40% of all malignant diseases diagnosed in this group. Genetic factors play a fundamental role in the genesis of the breast cancer in young patients. However, it is not easy to analyze them because their clinical usefulness is limited and there are multiple factors that must be considered. We conducted a retrospective study in which we included female patients of ages 40 years old or less, diagnosed with breast cancer at a private medical center during the period of January 2010 to July 2014. The protocol of the study included a complete clinical study, radiological reports as mammography and/or ultrasound image, histopathological and immunohistochemistry reports. The study included 46 patients with an average age of presentation of 37.1 years, a standard deviation (SD) of ±3.02 years and a median of 38 years. There were also different percentages for the various variables such as tumor characteristics, risk factors, and treatment provided. Young patients with breast cancer should be treated and evaluated individually by a multidisciplinary staff, as this pathological entity shows specific characteristics that makes this group of patients difficult to treat and warrants special considerations.

APA, Harvard, Vancouver, ISO, and other styles

31

Sen, Jayeeta. "Covid 19 Infection in Cancer Patients: An Institutional Study." Indian Journal of Cancer Education and Research 8, no. 1 (June 1, 2020): 29–33. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Gal, Danielle. "Cardiovascular Comorbidities Common in Patients with Metastatic Colorectal Cancer." Cancer Research and Cellular Therapeutics 2, no. 2 (August 1, 2018): 01–04. http://dx.doi.org/10.31579/2640-1053/025.

Full text

Abstract:

Aim: As comorbidities may impact treatment decisions, prognoses and quality of care, this study determined the rate of comorbid cardiovascular diseases in patients with metastatic colorectal cancer (mCRC). Methods: From the PHARMO Record Linkage System in The Netherlands, all patients with a hospital discharge code for CRC and distant metastasis from 2000–2008 were selected. Prevalent cardiovascular comorbidities were assessed during the 12 months prior to the index date (the first discharge diagnosis defining metastases). Cardiovascular comorbidities were captured using cardiovascular drug use and hospital admission data. 2964 patients with mCRC were included in the analysis. Mean (± standard deviation) age at diagnosis was 68 (± 12) years and 53% were male. Results: Cardiovascular comorbidities were observed in 52% of patients. Of patients identified by drug use, the most commonly used agents were antithrombotic agents (54%), beta-blocking agents (46%), and agents acting on the renin-angiotensin system (45%). Of patients hospitalised for cardiovascular comorbidities, about one-third were hospitalised for cardiac dysrhythmia (39%), followed by congestive heart failure (19%) and hypertension (18%). Conclusions: Cardiovascular comorbidities are common in patients with mCRC, which is likely to be explained by the high mean age at diagnosis. Consideration of these conditions should be integral to the treatment strategy in individual patients with mCRC.

APA, Harvard, Vancouver, ISO, and other styles

33

Fejzić, Hanifa. "Tumor marker CA 15-3 in breast cancer patients." Acta Medica Academica 44, no. 1 (June 2, 2015): 39–46. http://dx.doi.org/10.5644/ama2006-124.125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Vaalavirta, Leila, Nigora Rasulova, Kaarina Partanen, Timo Joensuu, and Kalevi Kairemo. "[18F]-Estradiol PET/CT Imaging in Breast Cancer Patients." Journal of Diagnostic Imaging in Therapy 1, no. 1 (October 7, 2014): 59–72. http://dx.doi.org/10.17229/jdit.2014-1007-004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Navghare, Tukaram, Aniket Muley, and Vinayak Jadhav. "Classification of Breast Cancer Patients using Deep Learning Techniques." Indian Journal Of Science And Technology 16, no. 47 (January 4, 2024): 4612–19. http://dx.doi.org/10.17485/ijst/v16i47.2758.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ginossar, Tamar. "Predictors of Online Cancer Prevention Information Seeking Among Patients and Caregivers Across the Digital Divide: A Cross-Sectional, Correlational Study." JMIR Cancer 2, no. 1 (March 9, 2016): e2. http://dx.doi.org/10.2196/cancer.5108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Asfaw, Alemseged Ayele, Connie H. Yan, Karen Sweiss, Scott Wirth, Victor H. Ramirez, Pritesh R. Patel, and Lisa K. Sharp. "Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study." JMIR Cancer 4, no. 2 (November 12, 2018): e12. http://dx.doi.org/10.2196/cancer.9918.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Kurniawan, Andree. "Sarcopenia in Cancer Patients." Indonesian Journal of Cancer 13, no. 3 (October 16, 2019): 96. http://dx.doi.org/10.33371/ijoc.v13i3.628.

Full text

Abstract:

Introduction: Sarcopenia in cancer patients, especially in advanced stage, recently known as an emerging problem. Firstly, sarcopenia is found in elderly patients. The diagnosis of sarcopenia needs evaluation of muscle composition and function and physical activity. Sarcopenia will give negative impacts such as increased mortality, chemo-toxicity, and decreased quality of life. Here, we review the current evidence describing the definition, impact, risk factors, mechanisms, diagnosis and treatment of sarcopenia in cancer patients.Method: We identified 48 studies and/or review articles evaluating sarcopenia in cancer patients by searching PubMed and EMBASE databases. Results: Sarcopenia is reported across all stages and types of cancers. There is a new definition of sarcopenia that is reported in 2019 paper. The risk factors or causes of sarcopenia in cancer are complex depending on the clinical settings of each patient. SARC-F questionnaire can be used to screen cancer patients in clinical settings. The diagnostic evaluation and cut-off measurement of sarcopenia especially in cancer varied across studies. The loss of muscle mass that happens during chemotherapy will make a poor prognosis. Sarcopenia can worsen chemotherapy toxicity. Combination exercise with adequate dietary supplementation, adequate energy, and protein are important in the management of sarcopenia in cancer patients.Conclusions: Patients with cancer belong to a population at risk of developing sarcopenia before and after chemotherapy. Sarcopenia diagnosis needs the evaluation of muscle mass and muscle strength or physical performance. Physical activity exercise is the best strategy to reduce sarcopenia in cancer patients.

APA, Harvard, Vancouver, ISO, and other styles

39

Chandio, Ashfaq, Anil Rai, Mehak Chandio, Asirvatham Rhody, and Katherine Brown. "Outcome of Colorectal cancer in Geriatric Patient." Cancer Research and Cellular Therapeutics 5, no. 4 (August 30, 2021): 01–07. http://dx.doi.org/10.31579/2640-1053/094.

Full text

Abstract:

Background: Older surgical patients remain at increased risk of adverse postoperative outcome when undergoing both elective and emergency surgery. The needs of the older surgical patient are often substantially different from those of younger patients. As a surgeons we have dilemmas in appropriately treating elderly patients. Specifically, those with cancer have been shown to receive inappropriate care, being either undertreated or overtreated based on their chronological age rather than their degree of frailty. Aim:To evaluate outcome of patients diagnosed with colorectal cancer in patients aged 80 years and over. Methods:Retrospective study of all patients 80 years and above managed with colorectal cancer at the Luton and Dunstable University Hospital UK from January 2015 through December 2019 Results: In the study period 278 patients were diagnosed with colorectal cancer, Male 143 Female 135 ratio 1:1.05. Age range from 80 to 101years. 54.31% patients underwent surgical intervention. 15.10% had complications after surgery. 36.69% patients deemed unsuitable for resection surgery were treated with best supportive care palliatively. 57.19% patients were in ASAIII, 24.10% ASAII and 12.23% ASAIV. 46.40% patients died during the study period. Conclusion:Age on its own would not be taken as for less aggressive therapy; Careful assessment of the patient taking into consideration comorbidities, functional status and patient wishes are essential in decision making and choosing appropriate management plan. Curative surgery for colorectal carcinoma in the geriatric patients are well tolerated. Management of comorbidities preceding surgery may impact postoperative outcome.

APA, Harvard, Vancouver, ISO, and other styles

40

Ogata, Takashi, Yota Shimoda, Kazuki Kano, Keisuke Koumori, Hayato Watanabe, Hirohito Fujikawa, Takanobu Yamada, and Takashi Oshima. "Screening and treatment strategy for double cancer for esophageal cancer surgery patients." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 336. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.336.

Full text

Abstract:

336 Background: Esophageal cancer treatment, especially esophagectomy, is highly invasive, so treatment strategies are considered in view of existing double cancers. On the other hand, in Japan, 90% of esophageal cancers are squamous cell carcinoma, and it is known that there are a large proportion of head and neck cancers for double cancers as field cancerization. Methods: The aim of this study is to investigate the types of double cancer, simultaneous/metachronous, and the frequency and treatment policy of head and neck cancer as a particularly high coexistence rate for esophageal cancer surgery patient. The subjects were 304 patients who underwent esophagectomy performed from April 2010 to December 2017. All patients were examined with high-definition endoscopy with NBI by certificated endoscopist at the first visit as a search for simultaneous double cancer from the pharynx to the stomach. And after esophagectomy, endoscopy was also performed to check for metachronous double cancers in the remaining esophagus, gastric tube, and pharynx at least every 2 years. Results: The number of double cancer cases was found in 94 cases (30.9%), and the total number of double cancer cases was 122. Head and neck cancer(33 cases), stomach cancer(16 cases), and colon cancer(12 cases) were observed as the main course of double cancers. In double cancer cases, 47cases(50.0%) were metachronous, 35cases(37.2%) were simultaneous, and 12cases(12.8%) were both synchronous. The most common double cancer was head and neck cancer(33 cases:35.1%), and 23 cases were simultaneous, 10 cases were metachronous. As treatment strategy for head and neck cancer, endoscopic laryngo-pharyngo surgery(ELPS) were 19 cases. 10 cases(52.7%) were synchronous cancers, and 9 cases (47.3%) were metachronous cancers which were detected during follow-up after esophagectomy. Conclusions: Head and neck cancer associated with esophageal cancer surgery is the most common type of double cancer, and 1/3 of ELPS cases have been detected by follow-up endoscopy after esophagectomy, so endoscopic surveillance was also considered important.

APA, Harvard, Vancouver, ISO, and other styles

41

SABZWARI, MOHAMMAD JAWAID, Muhammad Riaz, MUKHTAR AHMAD, Muhammad Umair, and MUHAMMAD TAHIR MAJEED. "CANCER PATIENTS." Professional Medical Journal 13, no. 03 (June 25, 2006): 344–48. http://dx.doi.org/10.29309/tpmj/2006.13.03.4979.

Full text

Abstract:

In the world cancer is one of the leading causes of death. Most cancerswhen detected early, can be potentially cured. Thus early laboratory diagnosis of cancer has great importance inmanagement. The tumor markers are one of the methods of cancer management in use today. Objectives: Tocompare serum sialic acid (SA) and carcinoembryonic antigen (CEA) as tumor markers in different cancer patients.Study Design: Prospective study Setting: Shaikh Zayed Medical Complex, Lahore. Material and Methods: Onehundred and fifty three (153) documented different cancer patients were studied to compare between serum sialic acidand carcinoembryonic antigen as a tumor marker along with fifty controls of matched sex and age distribution between30-85 years. The sialic acid was estimated by colorimetric procedure and carcinoembryonic antigen by EnzymeImmunoassay. Results: The results revealed that mean levels of sialic acid and CEA in cancer patients weresignificantly higher (p<0.05) as compared to controls, considering all malignancies together, or carcinoma,hematological malignancies and sarcoma alone. Statistical analysis showed sialic acid to be more sensitive (p<0.05)than CEA in detection of cancer. Conclusion: Sialic acid was seen to be a good diagnostic indicator as compared toCEA in most cancer patients.

APA, Harvard, Vancouver, ISO, and other styles

42

Muraoka, Kaori. "Cancer Patients." Japanese Journal of Rehabilitation Medicine 55, no. 3 (2018): 215–19. http://dx.doi.org/10.2490/jjrmc.55.215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Oyama, T., S. Baba, K. Hiraga, K. Mizuguchi, F. Suzuki, and M. Hyodo. "Patient's controlled analgesia in cancer patients." Pain 41 (January 1990): S354. http://dx.doi.org/10.1016/0304-3959(90)92823-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Kirkovits, Thomas, Timo Schinkoethe, Caroline Drewes, Caroline Gehring, Ingo Bauerfeind, Nadia Harbeck, and Rachel Wuerstlein. "eHealth in Modern Patient-Caregiver Communication: High Rate of Acceptance Among Physicians for Additional Support of Breast Cancer Patients During Long-Term Therapy." JMIR Cancer 2, no. 2 (September 19, 2016): e14. http://dx.doi.org/10.2196/cancer.5132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Shih, Chien, Cheng-Ping Wang, Pei-Jen Lou, Ya-Ling Hu, Tsung-Lin Yang, Jenq-Yuh Ko, and Shiann-Yann Lee. "Thyroid Cancer Incidentally Found in Radical Surgery for Laryngeal/Hypopharyngeal Cancer." Otolaryngology–Head and Neck Surgery 141, no. 3 (September 2009): 343–46. http://dx.doi.org/10.1016/j.otohns.2009.05.008.

Full text

Abstract:

OBJECTIVES: To report on four patients with thyroid cancer found in their specimen of laryngectomy for laryngeal/hypopharyngeal cancer. STUDY DESIGN: Retrospective case series. SETTING: Patients with laryngeal cancer and hypopharyngeal cancers treated at our institution between 1991 and 2005 were enrolled. SUBJECTS AND METHODS: There were 463 patients with laryngeal cancer and 219 patients with hypopharyngeal cancers under retrospective review. RESULTS: There were 254 patients with laryngeal caner and 130 patients with hypopharyngeal cancer receiving surgery. Thyroid cancer was observed in the resected thyroid gland in two cases of laryngeal cancer and in two cases of hypopharyngeal cancer. They received treatment only for their laryngeal/hypopharyngeal cancers. Two patients died of distant metastases from larynx/hypopharynx cancer within one year. The other two patients are currently alive without disease from either of the two types of cancer. CONCLUSIONS: It is rare to discover an unexpected simultaneous thyroid cancer confirmed postoperatively from thyroid tissue partially removed in laryngectomy. A conservative approach is suggested for such patients.

APA, Harvard, Vancouver, ISO, and other styles

46

MAEBAYASHI, TOSHIYA, NAOYA ISHIBASHI, TAKUYA AIZAWA, MASAKUNI SAKAGUCHI, KATSUHIKO SATO, TSUYOSHI MATSUI, KENYA YAMAGUCHI, and SATORU TAKAHASHI. "Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients." Anticancer Research 36, no. 9 (September 9, 2016): 4763–70. http://dx.doi.org/10.21873/anticanres.11033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Pahwa, Dr Sangeeta. "Expanding Horizon of Cervical Cancer Screening by Involving Antenatal Patients." Journal of Medical Science And clinical Research 04, no. 12 (December 21, 2016): 14805–13. http://dx.doi.org/10.18535/jmscr/v4i12.80.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Alqawi, Omar, Eman Elshahmi, Fatma Emaetig, Fauzia Elgaraboli, and Abubaker Abushnaf. "The Evaluation of PSA levels in Libyan Prostate Cancer Patients." Clinical Oncology Research and Reports 3, no. 1 (January 6, 2022): 01–05. http://dx.doi.org/10.31579/2693-4787/029.

Full text

Abstract:

Background: Prostate cancer is the second most frequent cancer and the fifth leading cause of cancer death in men with higher prevalence in the developed countries. The use of biomarkers for prostate cancer can improve the diagnosis of prostate cancer and clinical management of the patients. Prostate-specific antigen (PSA) is widely used to screen for prostate cancer and there is evidence that PSA testing reduces prostate cancer mortality. Objective: In this report we have studied the relationship between the Gleason score, age and PSA levels of prostate adenocarcinoma tissues from Libyan patients to evaluate the levels of PSA in prostate cancer patients. Materials and methods: The data was collected from medical files of 40 patients who underwent curative surgical prostatectomy or prostate true cut biopsy at National Cancer Institute (NCI)-Misurata, Libya during 2016 to 2018. The clinical and histopathological information included age, PSA levels, and Gleason score grade. Results: Our data showed that PSA level was statistically significant correlation with Gleason score grade (p- value = 0.007, <0.05). The increased serum PSA level was associated with the progression of prostate cancer. However, we found no statistically significant correlation between PSA and the age of patients (p- value = 0.435). Conclusion: Our data confirmed the association of high levels of PSA and the progress of prostate cancer.

APA, Harvard, Vancouver, ISO, and other styles

49

Hakeem, M. N. Lukmanul, and Dr V. Subathra Dr. V. Subathra. "A Study on the Burden of Caretakers of Cancer Patients." International Journal of Scientific Research 2, no. 3 (June 1, 2012): 382–84. http://dx.doi.org/10.15373/22778179/mar2013/126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Sujianto, Untung, Roland Billy, and Ani Margawati. "Family’s Experience: Nursing Care for Colorectal Cancer Patients with Colostomy." Nurse Media Journal of Nursing 10, no. 1 (April 24, 2020): 96–106. http://dx.doi.org/10.14710/nmjn.v10i1.28725.

Full text

Abstract:

Background: Colorectal cancer patients with colostomy have various complaints about changes in their life including the need for comprehensive and personal care. Ostomy nurses are responsible for managing people with a colostomy, and this particular nursing practice continues to develop globally. Also, previous literature highlights the importance of caregiver’s support, particularly family in colostomy patient care.Purpose: This study aimed to explore the family experience of colorectal cancer patients toward colostomy nursing careMethods: The study design used was descriptive phenomenology to explore the experience of ten participants through in-depth interviews. The participants were selected using purposive sampling with the inclusion criteria: family members of colorectal cancer patients with colostomy, over 21 years old, and able to communicate verbally. The data were analyzed using Colaizzi's method.Results: The results revealed three themes related to the family’s experience: (1) positive and negative behavior in nursing care, (2) living with a colostomy, (3) expectations for nursing care. The findings showed that the families were happy with the ostomy nursing care though some aspects needed to be improved. However, colorectal cancer patients experienced some difficulties in living with a colostomy.Conclusion: The study concluded that the colostomy nursing care still needs to be improved. This study recommends the ostomy nurses to improve their nursing care, especially in terms of skills, responsiveness, and awareness.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!